1. Home
  2. AIMD vs DSS Comparison

AIMD vs DSS Comparison

Compare AIMD & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • DSS
  • Stock Information
  • Founded
  • AIMD 1984
  • DSS 1984
  • Country
  • AIMD United States
  • DSS United States
  • Employees
  • AIMD N/A
  • DSS N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • AIMD Health Care
  • DSS Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • DSS Nasdaq
  • Market Cap
  • AIMD 8.2M
  • DSS 8.9M
  • IPO Year
  • AIMD N/A
  • DSS N/A
  • Fundamental
  • Price
  • AIMD $0.51
  • DSS $0.91
  • Analyst Decision
  • AIMD
  • DSS
  • Analyst Count
  • AIMD 0
  • DSS 0
  • Target Price
  • AIMD N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • AIMD 259.6K
  • DSS 186.4K
  • Earning Date
  • AIMD 08-04-2025
  • DSS 08-12-2025
  • Dividend Yield
  • AIMD N/A
  • DSS N/A
  • EPS Growth
  • AIMD N/A
  • DSS N/A
  • EPS
  • AIMD N/A
  • DSS N/A
  • Revenue
  • AIMD $106,207.00
  • DSS $20,180,000.00
  • Revenue This Year
  • AIMD N/A
  • DSS N/A
  • Revenue Next Year
  • AIMD N/A
  • DSS N/A
  • P/E Ratio
  • AIMD N/A
  • DSS N/A
  • Revenue Growth
  • AIMD 13.38
  • DSS 12.88
  • 52 Week Low
  • AIMD $0.40
  • DSS $0.72
  • 52 Week High
  • AIMD $1.07
  • DSS $1.75
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 38.36
  • DSS 49.41
  • Support Level
  • AIMD $0.49
  • DSS $0.79
  • Resistance Level
  • AIMD $0.52
  • DSS $1.03
  • Average True Range (ATR)
  • AIMD 0.05
  • DSS 0.07
  • MACD
  • AIMD -0.01
  • DSS -0.00
  • Stochastic Oscillator
  • AIMD 12.55
  • DSS 52.46

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: